Drugs / 27-35 (27L): melanoma antigen recognized by T-cells (MART)-1
27-35 (27L): melanoma antigen recognized by T-cells (MART)-1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00059475 | Apr 2003 → May 2010 | melanoma | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 27-35 (27L): melanoma antigen recognized by T-cells (MART)-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00059475 ↗ |